RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of EGRX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Eagle Pharmaceuticals stock price up 4.59% on Thursday
(Updated on Mar 28, 2024)

Sell candidate since Mar 18, 2024 Loss -6.76% PDF

The Eagle Pharmaceuticals stock price gained 4.59% on the last trading day (Thursday, 28th Mar 2024), rising from $5.01 to $5.24. During the last trading day the stock fluctuated 8.27% from a day low at $4.96 to a day high of $5.37. The price has fallen in 6 of the last 10 days and is down by -11.93% for this period. Volume fell on the last day by -31 thousand shares and in total, 69 thousand shares were bought and sold for approximately $360.81 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $5.03 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 17.75% during the next 3 months and, with a 90% probability hold a price between $5.92 and $8.00 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

EGRX Signals & Forecast

There are mixed signals in the stock today. The Eagle Pharmaceuticals stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $5.80. On a fall, the stock will find some support from the short-term average at $5.19. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not. A buy signal was issued from a pivot bottom point on Wednesday, March 27, 2024, and so far it has risen 4.59%. Further rise is indicated until a new top pivot has been found.

Support, Risk & Stop-loss for Eagle Pharmaceuticals stock

Eagle Pharmaceuticals finds support from accumulated volume at $5.23 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.410 between high and low, or 8.27%. For the last week the stock has had daily average volatility of 5.81%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (EGRX) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Eagle Pharmaceuticals to open at $5.19, and during the day (based on 14 day Average True Range), to move between $4.84 and $5.64, which gives a possible trading interval of +/-$0.403 (+/-7.70%) up or down from last closing price. If Eagle Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 15.40% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $5.23 (0.19%) than the resistance at $5.60 (6.87%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Eagle Pharmaceuticals stock A Buy?

Eagle Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.618 Sell Candidate Unchanged

Predicted Opening Price for Eagle Pharmaceuticals of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$5.19 ( 0.95%) $5.24

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for EGRX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.60 6.87 %
R2 5.44 3.88 %
R1 5.35 2.03 %
Current price: 5.24
Support S1 5.03 -3.94 %
S2 4.94 -5.79 %
S3 4.78 -8.78 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.86 11.83 %
R2 5.85 11.64 %
R1 5.60 6.87 %
Current price 5.24
Support S1 5.23 -0.191%
S2 4.73 -9.73%
S3 4.53 -13.55%

FAQ

What is the symbol for Eagle Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Eagle Pharmaceuticals is EGRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Eagle Pharmaceuticals Stock?
Eagle Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Eagle Pharmaceuticals Stock?
Eagle Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Eagle Pharmaceuticals Stock.

What's the current price of Eagle Pharmaceuticals Stock?
As of the end of day on the 2024-03-28, the price of an Eagle Pharmaceuticals (EGRX) share was $5.24.

What is the 52-week high and low for Eagle Pharmaceuticals Stock?
The 52-week high for Eagle Pharmaceuticals Stock is $32.44 and the 52-week low is $4.10.

What is the market capitalization of Eagle Pharmaceuticals Stock?
As of the 2024-03-28, the market capitalization of Eagle Pharmaceuticals is 65.065M.

When is the next earnings date for Eagle Pharmaceuticals?
The upcoming earnings date for Eagle Pharmaceuticals is Apr 01, 2024.
Click to get the best stock tips daily for free!

About Eagle Pharmaceuticals

Eagle Pharmaceuticals Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also include EP-4104, a dantrolene sodium ... EGRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT